FebriDx FDA CLIA wavier approval unlocks upside for Pascal
Filed with ASX · · 2 pages · English
Story so far
Earlier from Atomo Diagnostics
- Trading Halt
- Pause in Trading
- Response to ASX Price Query
- H1 FY26 Results Presentation
- Appendix 4D and Half Year Report ended 31 Dec 2025
Later from Atomo Diagnostics
- Atomo Completes Capital Raise
- Response to ASX Aware Letter
- Share Purchase Plan Results
- Managing Director & CEO Transition
- Final Director's Interest Notice
Follow Atomo Diagnostics into a list and get an email when it puts out news.
Follow Atomo Diagnostics